未登录

Ł

Łukasz Pyka

Medical University Silesia

H指数:13

被引数:557

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reviving a failing heart in real life: Are the results of the REVIVED trial applicable to an all-comer population?

KARDIOLOGIA POLSKA

IF3.7

2023-10-310

OA

Outcomes of coronary revascularization vs. optimal medical therapy alone for ischemic left ventricular dysfunction: A meta-analysis of randomized controlled trials

KARDIOLOGIA POLSKA

IF3.7

2023-10-010

OA

Alert Transmissions From Remote Monitoring of Patients With Cardiac Implantable Devices

JACC-CLINICAL ELECTROPHYSIOLOGY

IF7.7

2023-10-012

OAAI

Prognostic Value of Spot Urinary Creatinine Concentration and Its Relationship with Body Composition Parameters in HF Patients

IF3.9

2023-05-122

OAAI

Factors affecting short- and long-term survival of patients with acute coronary syndrome treated invasively using intravascular ultrasound and fractional flow reserve: Analysis of data from the Polish Registry of Acute Coronary Syndromes 2017-2020

KARDIOLOGIA POLSKA

IF3.7

2023-03-2710

OA

Orbital atherectomy for heavily calcified coronary lesions in a patient with heart failure and severely impaired left ventricular ejection fraction

KARDIOLOGIA POLSKA

IF3.7

2023-02-280

OA

Aspiration thrombectomy for patients with acute coronary syndromes and culprit lesions located in coronary bypass grafts. Data from the PL-ACS registry

KARDIOLOGIA POLSKA

IF3.7

2022-08-311

OA

In-vitro mechanical behavior and in-vivo healing response of a new generation biodegradable polymer-coated thin-strut sirolimus-eluting stents

KARDIOLOGIA POLSKA

IF3.7

2022-01-310

OA

The increased rate of life-threatening interventions in remotely monitored patients with heart failure during the coronavirus disease 2019 pandemic

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ

IF4.7

2020-07-083

OA

How to effectively analyze scientific evidence in clinical practice? Rationale behind and design of an observational analytical model

KARDIOLOGIA POLSKA

IF3.7

2020-06-252

OA

Long-term clinical outcomes after placement of an implantable cardioverter-defibrillator: does the etiology of heart failure matter?

KARDIOLOGIA POLSKA

IF3.7

2020-04-248

OA

Atrial fibrillation and myocardial infarction - in constant need for new data

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

IF7.5

2019-05-082

OAAI

Mortality risk factors in patients with advanced heart failure and diabetes mellitus

晚期心力衰竭合并糖尿病患者死亡危险因素分析

KARDIOLOGIA POLSKA

IF3.7

2019-04-2613

OA

Community screening for heart failure with preserved ejection fraction

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

IF7.5

2019-02-053

OAAI

Aerobic as well as resistance exercises are good for patients with type 1 diabetes

有氧运动和抗阻运动对1型糖尿病患者有好处

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2018-10-0116

PREAI

Temporal trends in secondary prevention in myocardial infarction patients discharged with left ventricular systolic dysfunction in Poland

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

IF7.5

2018-04-2526

PREAI

Red blood cell distribution width, relative lymphocyte count, and type 2 diabetes predict all-cause mortality in patients with advanced heart failure

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ

IF4.7

2017-11-0914

OA

The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up

KARDIOLOGIA POLSKA

IF3.7

2017-06-1912

PRE

Complete percutaneous revascularisation feasibility in ischaemic heart failure is related to improved outcomes: insights from the COMMIT-HF registry

KARDIOLOGIA POLSKA

IF3.7

2017-05-175

PRE

Impact of Chronic Total Occlusion of the Coronary Artery on Long-Term Prognosis in Patients With Ischemic Systolic Heart Failure Insights From the COMMIT-HF Registry

JACC-CARDIOVASCULAR INTERVENTIONS

IF11.4

2016-09-0164

OAAI